126 related articles for article (PubMed ID: 30968301)
1. Variation in platelet expression of FcγRIIa after myocardial infarction.
McMahon SR; Chava S; Taatjes-Sommer HS; Meagher S; Brummel-Ziedins KE; Schneider DJ
J Thromb Thrombolysis; 2019 Jul; 48(1):88-94. PubMed ID: 30968301
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Cardiovascular Risk by the Combination of Clinical Risk Scores Plus Platelet Expression of FcγRIIa.
Schneider DJ; McMahon SR; Ehle GL; Chava S; Taatjes-Sommer HS; Meagher S
Am J Cardiol; 2020 Mar; 125(5):670-672. PubMed ID: 31883679
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa.
Miao S; Shu D; Zhu Y; Lu M; Zhang Q; Pei Y; He AD; Ma R; Zhang B; Ming ZY
Cell Death Dis; 2019 Jan; 10(2):87. PubMed ID: 30692520
[TBL] [Abstract][Full Text] [Related]
4. Individual long-term variation of platelet reactivity in patients with dual antiplatelet therapy after myocardial infarction.
Alfredsson J; Swahn E; Gustafsson KM; Janzon M; Jonasson L; Logander E; Nilsson L; Lindahl TL
Platelets; 2019; 30(5):572-578. PubMed ID: 29869923
[TBL] [Abstract][Full Text] [Related]
5. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.
Yeung J; Tourdot BE; Fernandez-Perez P; Vesci J; Ren J; Smyrniotis CJ; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; McKenzie SE; Holinstat M
Blood; 2014 Oct; 124(14):2271-9. PubMed ID: 25100742
[TBL] [Abstract][Full Text] [Related]
6. A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.
Rijkers M; Saris A; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Bierings R; Leebeek FWG; Jansen AJG; Vidarsson G; Voorberg J; de Haas M
Haematologica; 2018 Oct; 103(10):1741-1752. PubMed ID: 29858387
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton's Tyrosine Kinase.
Duan R; Goldmann L; Li Y; Weber C; Siess W; von Hundelshausen P
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008508
[TBL] [Abstract][Full Text] [Related]
8. Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy.
Marcucci R; Paniccia R; Antonucci E; Poli S; Gori AM; Valente S; Giglioli C; Lazzeri C; Prisco D; Abbate R; Gensini GF
Thromb Haemost; 2007 Oct; 98(4):844-51. PubMed ID: 17938810
[TBL] [Abstract][Full Text] [Related]
9. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
[TBL] [Abstract][Full Text] [Related]
10. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
[TBL] [Abstract][Full Text] [Related]
11. Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.
Zhou Y; Abraham S; Andre P; Edelstein LC; Shaw CA; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
Blood; 2015 Dec; 126(26):2871-81. PubMed ID: 26516227
[TBL] [Abstract][Full Text] [Related]
12. Platelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease and cancer.
Zhang Q; Li W; Mao X; Miao S
Thromb Res; 2024 Jun; 238():19-26. PubMed ID: 38643522
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
14. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation: results of a randomized, cross-over trial.
Hally KE; La Flamme AC; Harding SA; Larsen PD
Platelets; 2019; 30(5):599-607. PubMed ID: 29869943
[TBL] [Abstract][Full Text] [Related]
15. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3.
Pampolina C; McNicol A
Thromb Haemost; 2005 May; 93(5):932-9. PubMed ID: 15886812
[TBL] [Abstract][Full Text] [Related]
17. Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis.
Calverley DC; Brass E; Hacker MR; Tsao-Wei DD; Espina BM; Pullarkat VA; Hodis HN; Groshen S
Atherosclerosis; 2002 Oct; 164(2):261-7. PubMed ID: 12204796
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel Syk-independent functional roles of FcγRIIa in platelet outside-in signaling using transgenic mice expressing human FcγRIIa.
Buitrago L; Manne BK; Andre P; McKenzie S; Kunapuli S
Platelets; 2016 Jul; 27(5):488-90. PubMed ID: 26809427
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
[TBL] [Abstract][Full Text] [Related]
20. The platelet Fc receptor, FcγRIIa.
Qiao J; Al-Tamimi M; Baker RI; Andrews RK; Gardiner EE
Immunol Rev; 2015 Nov; 268(1):241-52. PubMed ID: 26497525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
